Trials / Completed
CompletedNCT03565211
Clinical Safety Study of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology Procedures
A Prospective, Multi-Center, Non-Comparative Trial of the Clinical Safety of the Progesterone Vaginal Ring in Women Undergoing Assisted Reproductive Technology (ART) Procedures
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 352 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- Female
- Age
- 18 Years – 34 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the safety of Progesterone Vaginal Ring (PVR) in women undergoing fresh embryo transfer (ART).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Progesterone vaginal ring | A flexible, non-degradable PVR containing progesterone in micronized formulation and dispersed evenly throughout the ring. |
Timeline
- Start date
- 2018-07-26
- Primary completion
- 2019-07-29
- Completion
- 2019-07-29
- First posted
- 2018-06-21
- Last updated
- 2020-11-23
- Results posted
- 2020-11-23
Locations
15 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03565211. Inclusion in this directory is not an endorsement.